当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析 - 现金流量表

安图生物

(603658)

  

流通市值:219.08亿  总市值:219.08亿
流通股本:5.71亿   总股本:5.71亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,616,642,408.452,350,992,101.121,189,097,872.314,702,576,301.33
  收到的税费返还6,710,602.973,306,407.04773,234.8621,408,259.98
  收到其他与经营活动有关的现金79,004,471.3568,289,117.0640,724,021.7195,252,223.18
  经营活动现金流入小计3,702,357,482.772,422,587,625.221,230,595,128.874,919,236,784.49
  购买商品、接受劳务支付的现金1,357,687,358.63875,490,223.45363,392,484.111,467,448,287.22
  支付给职工以及为职工支付的现金988,340,220.99721,072,379.93475,721,428.361,159,015,933.18
  支付的各项税费420,666,951.06321,510,192.5126,410,106.27487,966,552.96
  支付其他与经营活动有关的现金401,966,383.68288,672,868.31118,498,609.63463,124,248.38
  经营活动现金流出小计3,168,660,914.362,206,745,664.191,084,022,628.373,577,555,021.74
  经营活动产生的现金流量净额533,696,568.41215,841,961.03146,572,500.51,341,681,762.75
二、投资活动产生的现金流量:
  收回投资收到的现金7,569,666.76,745,925.693,450,961.66-
  取得投资收益收到的现金3,130,2182,235,8702,235,870894,348
  处置固定资产、无形资产和其他长期资产收回的现金净额7,0007,000-109,282.3
  收到的其他与投资活动有关的现金7,777,515,828.316,027,008,639.792,222,136,910.874,979,269,563.55
  投资活动现金流入小计7,788,222,713.016,035,997,435.482,227,823,742.534,980,273,193.85
  购建固定资产、无形资产和其他长期资产支付的现金354,901,233.65226,813,702.18133,159,505.15604,302,271.16
  投资支付的现金91,315,39488,499,49488,499,49417,500,000
  支付其他与投资活动有关的现金7,122,620,279.134,461,233,511.331,836,927,142.314,773,821,435.96
  投资活动现金流出小计7,568,836,906.784,776,546,707.512,058,586,141.465,395,623,707.12
  投资活动产生的现金流量净额219,385,806.231,259,450,727.97169,237,601.07-415,350,513.27
三、筹资活动产生的现金流量:
  吸收投资收到的现金---14,455,000
  其中:子公司吸收少数股东投资收到的现金---14,455,000
  取得借款收到的现金3,042,046.613,042,046.613,000,000364,670,786.89
  收到其他与筹资活动有关的现金1,085,000,000845,010,000160,850,0001,639,509,118.12
  筹资活动现金流入小计1,088,042,046.61848,052,046.61163,850,0002,018,634,905.01
  偿还债务支付的现金42,046.61--852,670,786.89
  分配股利、利润或偿付利息支付的现金752,208,203.57751,647,626.15283,730.83728,785,691.1
  其中:子公司支付给少数股东的股利、利润2,004,1002,004,100-2,102,100
  支付其他与筹资活动有关的现金1,056,540,476.85895,610,578.28265,573,745.221,233,471,317.45
  筹资活动现金流出小计1,808,790,727.031,647,258,204.43265,857,476.052,814,927,795.44
  筹资活动产生的现金流量净额-720,748,680.42-799,206,157.82-102,007,476.05-796,292,890.43
四、汇率变动对现金及现金等价物的影响-25,274,361.4-17,706,566.05-7,662,969.99774,015.75
五、现金及现金等价物净增加额7,059,332.82658,379,965.13206,139,655.53130,812,374.8
  加:期初现金及现金等价物余额582,870,723.61582,870,723.61582,870,723.61452,058,348.81
  期末现金及现金等价物余额589,930,056.431,241,250,688.74789,010,379.14582,870,723.61
补充资料:
  净利润-502,204,100.87-1,086,384,222.05
  资产减值准备--536,333.46-19,708,750.29
  固定资产和投资性房地产折旧-202,021,045.69-427,857,927.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-202,021,045.69-427,857,927.85
  无形资产摊销-16,687,046.24-28,181,990.29
  长期待摊费用摊销-15,671,432.51-27,694,870.94
  处置固定资产、无形资产和其他长期资产的损失----637,786.38
  固定资产报废损失-2,574,068.07-4,965,505.65
  公允价值变动损失--28,802.44-3,495,613.67
  财务费用-13,663,464.09-15,562,007.36
  投资损失--29,718,977.45--104,506,851.42
  递延所得税--13,351,807.44--51,008,060.49
  其中:递延所得税资产减少--28,286,424.28--13,546,443.34
    递延所得税负债增加-14,934,616.84--37,461,617.15
  存货的减少--297,211,057.82--284,740,441.26
  经营性应收项目的减少--6,270,958.79-30,432,966.6
  经营性应付项目的增加--213,041,177.14-129,163,358.86
  其他-19,379,412.19--8,262,674.71
  现金的期末余额-1,241,250,688.74-582,870,723.61
  减:现金的期初余额-582,870,723.61-452,058,348.81
  现金及现金等价物的净增加额-658,379,965.13-130,812,374.8
公告日期2026-10-272026-08-252026-04-232026-04-23
审计意见(境内)标准无保留意见
TOP↑